492 related articles for article (PubMed ID: 19148551)
1. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
4. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I.
Beecken WD; Engl T; Ringel EM; Camphausen K; Michaelis M; Jonas D; Folkman J; Shing Y; Blaheta RA
Ann Surg Oncol; 2006 Sep; 13(9):1241-51. PubMed ID: 16955386
[TBL] [Abstract][Full Text] [Related]
5. Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
Shariat SF; Youssef RF; Gupta A; Chade DC; Karakiewicz PI; Isbarn H; Jeldres C; Sagalowsky AI; Ashfaq R; Lotan Y
J Urol; 2010 May; 183(5):1744-50. PubMed ID: 20299037
[TBL] [Abstract][Full Text] [Related]
6. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
Du Z; Hou S
J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
[TBL] [Abstract][Full Text] [Related]
7. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene.
Oga M; Takenaga K; Sato Y; Nakajima H; Koshikawa N; Osato K; Sakiyama S
Int J Oncol; 2003 Jul; 23(1):73-9. PubMed ID: 12792778
[TBL] [Abstract][Full Text] [Related]
11. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
Xu XL; Liu GF; Huang DY
Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
[TBL] [Abstract][Full Text] [Related]
12. Endostatin signaling and regulation of endothelial cell-matrix interactions.
Wickström SA; Alitalo K; Keski-Oja J
Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
[TBL] [Abstract][Full Text] [Related]
13. The novel targets for anti-angiogenesis of genistein on human cancer cells.
Su SJ; Yeh TM; Chuang WJ; Ho CL; Chang KL; Cheng HL; Liu HS; Cheng HL; Hsu PY; Chow NH
Biochem Pharmacol; 2005 Jan; 69(2):307-18. PubMed ID: 15627483
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
15. A comparison of antiangiogenic therapies for the prevention of liver metastases.
Mi J; Sarraf-Yazdi S; Zhang X; Cao Y; Dewhirst MW; Kontos CD; Li CY; Clary BM
J Surg Res; 2006 Mar; 131(1):97-104. PubMed ID: 16242720
[TBL] [Abstract][Full Text] [Related]
16. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
17. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
[TBL] [Abstract][Full Text] [Related]
18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
19. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes.
Kim KS; Kim HS; Park JS; Kwon YG; Park YS
Cancer Gene Ther; 2004 Jun; 11(6):441-9. PubMed ID: 15118757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]